Oral treatment of pernicious anemia with high doses of vitamin b12 without intrinsic factor

This paper is only available as a PDF. To read, Please Download here.

Abstract

A large group of patients with pernicious anemia has been treated with vitamin B12 for periods as long as forty months. Parenterally administered B12 was as effective as refined liver extract in producing and maintaining clinical and hematologic remission. No evidence was found that patients with uncomplicated pernicious anemia need any therapy other than vitamin B12. Orally administered vitamin B12 was effective in the treatment of pernicious anemia provided that the oral dose was about 100 times the amount which was adequate when given parenterally. Until the adequacy of oral dosage schedules has been demonstrated patients with pernicious anemia should receive parenteral therapy. An intramuscular injection of 45 μg. of vitamin B12 given every six weeks appeared to be adequate for satisfactory maintenance therapy and protected against hematologic and neurologic relapse. Vitamin B12 seems preferable to liver extract in the treatment of pernicious anemia because it causes less discomfort at the site of injection, does not give rise to untoward reactions and is less expensive than liver extract.

To read this article in full you will need to make a payment

References

    • Rickes E.L.
    • Brink N.G.
    • Koniuszy F.R.
    • Wood T.R.
    • Folkers K.

    Crystalline vitamin B12.

    Science. 1948; 107: 396

    • Scopus (183)
    • PubMed
    • Crossref
    • Google Scholar

    • Smith E.L.

    Purification of anti-pernicious anaemia factor from liver.

    Nature. 1948; 161: 638

    • Scopus (84)
    • PubMed
    • Crossref
    • Google Scholar

    • West R.

    Activity of vitamin B12 in Addisonian pernicious anemia.

    Science. 1948; 107: 398

    • Scopus (17)
    • PubMed
    • Crossref
    • Google Scholar

    • West R.
    • Reisner Jr., E.H.

    Treatment of pernicious anemia with crystalline vitamin B12.

    Am. J. Med. 1949; 6: 643

    • Scopus (2)
    • PubMed
    • Abstract
    • Full Text PDF
    • Google Scholar

    • Ungley C.C.

    Vitamin B12 in pernicious anemia: parenteral administration.

    Brit. M. J. 1949; 2: 1370

    • Scopus (3)
    • PubMed
    • Crossref
    • Google Scholar

    • Strauss M.B.

    Vitamin B12 and pernicious anemia.

    New England J. Med. 1950; 243: 187

    • PubMed
    • Crossref
    • Google Scholar

    • Strauss M.B.

    Vitamin B12 and pernicious anemia.

    New England J. Med. 1950; 243: 222

    • Scopus (1)
    • PubMed
    • Crossref
    • Google Scholar

    • Castle W.B.

    Present status of the etiology of pernicious anemia.

    Ann. Int. Med. 1951; 34: 1093

    • Scopus (2)
    • PubMed
    • Crossref
    • Google Scholar

    • Berk L.
    • Castle W.B.
    • Welch A.D.
    • Heinle R.W.
    • Anker R.
    • Epstein M.

    Observations on the etiologic relationship of achylia gastrica to pernicious anemia. X. Activity of vitamin B12 as food (extrinsic) factor.

    New England J. Med. 1948; 239: 911

    • Scopus (11)
    • PubMed
    • Crossref
    • Google Scholar

    • Hall B.E.
    • Morgan E.H.
    • Campbell D.C.

    Oral administration of vitamin B12 in pernicious anemia. I. Presence of intrinsic factor in Berkefeld-filtered pooled human gastric juice; preliminary report.

    in: 2nd ed. Proc. Staff Meet., Mayo Clin.24. 1949: 99

    • Google Scholar

    • Heinle R.W.
    • Welch A.D.

    Folie acid in pernicious anemia. Failure to prevent neurologic relapse.

    J. A. M. A. 1947; 133: 739

    • Scopus (21)
    • PubMed
    • Crossref
    • Google Scholar

    • Spies T.D.
    • Garcia Lopez G.
    • Milanes F.
    • Lopez Toca R.
    • Reboredo A.

    Folic acid and vitamin B12 in anemia.

    Gen. Practitioner. 1950; 11: 37

    • Google Scholar

    • Owren P.A.

    Is B12the Complete Therapeutic Answer in Pernicious Anemia?.

    in: Proceedings of the Third International Congress of the International Society of Hematology. Grune & Stratton, New York1951: 22-24

    • Google Scholar

    • Conley C.L.
    • Krevans J.R.

    Development of neurologic manifestations of pernicious anemia during multivitamin therapy.

    New England J. Med. 1951; 245: 529

    • Scopus (20)
    • PubMed
    • Crossref
    • Google Scholar

    • Conley C.L.
    • Krevans J.R.
    • Chow B.F.
    • Barrows C.
    • Lang C.A.

    Observations on the absorption, utilization and excretion of vitamin B12.

    J. Lab. & Clin. Med. 1951; 38: 84

    • PubMed
    • Google Scholar

  1. Paulson, M. and Harvey, J. C. To be published.

    • Google Scholar

    • Buhs R.P.
    • Newstead E.G.
    • Trenner N.

    An analog of vitamin B12.

    Science. 1951; 113: 625

    • Scopus (4)
    • PubMed
    • Crossref
    • Google Scholar

    • James III, G.W.
    • Abbott Jr., L.D.

    Effectiveness of thiocyanate analog of vitamin B12 in pernicious anemia.

    in: 2nd ed. Proc. Soc. Exper. Biol. & Med.77. 1951: 416

    • Google Scholar

    • Meyer L.M.
    • Sawitsky A.
    • Fink H.
    • Ritz N.D.
    • Krim M.

    Treatment of pernicious anemia with crystalline vitamin B12.

    in: 2nd ed. Proc. Soc. Exper. Biol. & Med.75. 1950: 366

    • Google Scholar

    • Bortz D.W.
    • Battle J.D.

    Massive vitamin B12 therapy in pernicious anemia.

    Cleveland Clin. Quart. 1950; 17: 166

    • PubMed
    • Crossref
    • Google Scholar

    • Spies T.D.
    • Stone R.E.
    • Garcia Lopez G.
    • Milanes F.
    • Lopez Toga R.
    • Aramburu T.

    Observations on vitamin B12 as an antianemic substance.

    Internat. Rev. Vitamin Research. 1949; 21: 328

    • Google Scholar

    • Morgan E.H.
    • Hall B.E.
    • Campbell D.C.

    Oral Administration of Vitamin B12 in Pernicious Anemia. III. Effect of Oral Administration of Vitamin B12 in the Absence of Known Sources of Intrinsic Factor.

    in: Proceedings of the Third International Congress of the International Society of Hematology. Grune & Stratton, New York1951: 7-11

    • Google Scholar

    • Ungley C.C.

    Absorption of vitamin B12 in pernicious anemia. I. Oral administration without a source of intrinsic factor.

    Brit. M. J. 1950; 2: 905

    • Scopus (12)
    • PubMed
    • Crossref
    • Google Scholar

    • Schwartz S.O.
    • Legere H.

    Relapses in pernicious anemia.

    J. A. M. A. 1944; 124: 637

    • Scopus (1)
    • Crossref
    • Google Scholar

    • Jones E.
    • Tillman C.C.
    • Darby W.J.

    Observations on relapses in pernicious anemia.

    Ann. Int. Med. 1949; 30: 374

    • Scopus (1)
    • PubMed
    • Crossref
    • Google Scholar

    • Vilter R.W.
    • Horrigan D.
    • Mueller J.F.
    • Jarrold T.
    • Vilter C.F.
    • Hawkins V.
    • Seaman A.

    Studies on the relationships of vitamin B12, folic acid, thymine, uracil, and methyl group donors in persons with pernicious anemia and related megaloblastic anemias.

    Blood. 1950; 5: 695

    • PubMed
    • Crossref
    • Google Scholar

    • Chodos R.B.
    • Ross J.F.

    The effects of combined folic acid and liver extract therapy.

    Blood. 1951; 6: 1213

    • PubMed
    • Google Scholar

    • Larsen G.

    The Pathogenesis of the Macrocyte.

    in: Proceedings of the Third International Congress of the International Society of Hematology. Grune & Stratton, New York1951: 25-33

    • Google Scholar

    • Beard M.F.
    • McIlvanie S.K.

    Vitamin B12 as a Hemotherapeutic Agent in Pernicious Anemia.

    in: Proceedings of the Third International Congress of the International Society of Hematology. Grune & Stratton, New York1951: 34

    • Google Scholar

    • Owren P.A.

    The Deficiency of a Factor Necessary for Normal Protein Synthesis in the Liver in Pernicious Anemia.

    in: Proceedings of the Third International Congress of the International Society of Hematology. Grune & Stratton, New York1951: 34-35

    • Google Scholar

Article Info

Footnotes

☆This investigation was in part carried out under contract number AT (30-1)—1208 between the Atomic Energy Commission and the Johns Hopkins University, and in part supported by research grants from the National Vitamin Foundation and the Squibb Institute for Therapeutic Research.

Identification

DOI: https://doi.org/10.1016/0002-9343(52)90283-0

Copyright

© 1952 Published by Elsevier Inc.

ScienceDirect

Access this article on ScienceDirect

Can pernicious anemia be treated with oral B12?

For long-term maintenance therapy, oral vitamin B12 replacement can be effective in patients with pernicious anemia.

Why is oral administration of vitamin B12 not effective as a treatment for pernicious anemia?

This belief is still being propagated, as this quote from an article published recently attests: “Pernicious anemia is caused by inadequate secretion of gastric intrinsic factor necessary for vitamin B12 absorption and thus cannot be treated with oral vitamin B12 supplements; rather, vitamin B12 must be administered ...

Can you absorb B12 without intrinsic factor?

A small amount of vitamin B12 is absorbed by passive diffusion without intrinsic factor.

Can you have pernicious anemia without intrinsic factor antibodies?

A negative test result does not necessarily mean that a person does not have pernicious anemia. As many as half of those affected will not have IF antibodies.